The Report Guru

According to research report the  sinus dilation devices market  is expected to reach USD 2.78 billion by 2023 from USD 1.80 billion in 2018, at a CAGR of 9.1%. The growth of this market is mainly driven by the high prevalence of chronic sinusitis, growing preference for minimally invasive procedures, benefits of balloon sinuplasty/sinus dilation over conventional sinus surgeries, and favorable reimbursement scenario for sinus procedures in developed countries. Benefits of balloon sinuplasty / sinus dilation over conventional sinus surgeries to drive the growth of sinus dilation devices market Hospitals Hospitals is one of the patient care settings where sinus dilation devices are extensively used. This segment holds the largest market share due to high number of outpatient sinus dilation procedures, the advantages of having integrated healthcare facilities, the availability of technologically advanced infrastructures, and the ability to perform complex sinus surgeries. Amb

The prominent players in the dental equipment market are 3M Company (U.S.), A-dec Inc. (U.S.), BIOLASE Technology (U.S.), Carestream Health (U.S.), Danaher Corporation (U.S.), Dentsply International (U.S.), Ivoclar Vivadent (Liechtenstein), Midmark Corporation (U.S.), Planmeca Oy (Finland), and Sirona Dental Systems Inc. (U.S.). Danaher Corporation (U.S.) was the global leader in the dental equipment market in 2013. It is a well-known company and has an exhaustive product portfolio. The company adopted acquisitions as its key business strategy to uphold its leadership position in the dental equipment market. In this regard, in June 2014, Kerr Corporation (a subsidiary of Danaher Corporation) acquired DUX Dental (U.S.) and Vettec Inc. (U.S.), two dental imaging companies. According to research report dental equipments market is projected to reach USD 7.5 billion by 2021 from USD 5.9 billion in 2016, at a CAGR of 4.9%. K

Prominent players in the wearable medical device market include Fitbit Inc. (U.S.), Philips Healthcare (Netherlands), Garmin Ltd. (Switzerland), LifeWatch AG. (Switzerland), Omron Corporation (Japan), Drägerwerk AG & Co. KGaA (U.S.), Withings SA.(France), Jawbone Inc. (U.S.) and Polar Electro Oy (Finland). According to research report wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 5.31 Billion in 2016, at a CAGR of 18.3% during the forecast period Know more: https://www.marketsandmarkets.com/Market-Reports/wearable-medical-device-market-81753973.html For estimating the size of the wearable medical device market, the segmental market revenues were obtained from secondary sources through extensive primary interviews. The segment-level markets were then added up to reach the total market size of each segment (type, distribution channel, End use, and applications). The wearable medical device market size was derived by adding the mark

According to research report the global in vitro toxicology testing market is projected to reach USD 8.74 billion by 2022 from USD 6.34 billion in 2017, at a CAGR of 6.6% during the forecast period. Objectives of the Study To define, describe, and forecast the global market by product & service, toxicity endpoint & test, technology, method, industry, and region To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges) To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World To profile key players and comprehensively analy

The key players in the spinal implants and surgical device market focus on various strategies such as new product launches and product enhancements; mergers and acquisitions; geographic expansions; and partnerships, agreements, and collaborations in order to strengthen their global position in the spinal implants and surgical devices market. New product launches and product enhancements was the key growth strategy adopted by a majority of the industry players to increase their share the spinal implants and surgical devices market. Companies such as Medtronic, plc (Ireland), NuVasive, Inc. (U.S.), Globus Medical, Inc. (U.S.), Alphatec Holdings, Inc. (U.S.), Orthofix International N.V. (Netherlands), K2M Group Holdings, Inc. (U.S.), RTI Surgical, Inc. (U.S.) majorly adopted this strategy. Apart from product launches and enhancements, a number of leading players adopted the strategy of partnerships, agreements, and collaborations to strengthen their sales and distribution

According to the new market research report “ Surgical Microscopes Market  is poised to reach USD 915.6 Million by 2021 from USD 508.1 Million in 2016, at a CAGR of 12.5% from 2016 to 2021. The increasing use of fluorescence image-guided surgery (FIGS), increase in the number of surgeries and growing demand for MIS, advancements in healthcare facilities, technological advancements, and customized microscopy solutions are the key factors driving the growth of the global surgical microscopes market. However, factors such as high cost of advanced surgical/operating microscopes, implementation of excise tax by the U.S. government, and high custom duties on medical devices are restraining the growth of this market to a certain extent. The global surgical microscopes market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented into neuro and spine surgery, plastic and reconstructive surgery, ophthalmology, gynecology and ur

The  spirometers market  is expected to reach USD 1,047 million  by 2023 from USD 655 million in 2018, at a CAGR of 9.8%. Market growth is  largely driven by the rising global incidence of respiratory diseases, global  population, and technological advancements in spirometer devices. Opportunities  for growth of the market exist in emerging economies on account of increasing pollution  levels and rising awareness regarding COPD and other respiratory conditions. On   the other hand, the time required to carry out tests using spirometers and data  accuracy issues associated with personalized spirometers are expected to limit  market growth during the forecast period. The spirometers market is highly consolidated in nature, with a few players offering a variety of products. The major players operating in this market are Hill Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), N

 According to research report  oral care market  is expected to grow from USD 41.56 billion in 2017 to USD 53.97 billion by 2023, at a CAGR of 4.5% from 2017 to 2022. Oral care products are used for the diagnosis, treatment, and prevention of dental diseases; maintenance of oral hygiene; or postoperative care. These products include toothbrushes, toothpastes, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthetic cleaning solutions. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022. Market Dynamics Drivers Growing awareness on oral hygiene Technological advancements in oral care products Rising incidence of dental caries and other periodontal diseases Restraints Competitive pricing pressure faced by prominent players Opportunities Untapped emerging markets Increasing online purchase of oral care products Challenges High dependence on retail store

According to research report the optical imaging market is expected to be at USD 989.0 Million in 2015, growing at a CAGR of 12.1% during the forecast period. The optical imaging market offers powerful modalities for molecular imaging in clinical diagnostics and preclinical research in various therapeutic areas. Rising aging population, increase in R&D activities in the life sciences sector, and growing demand of optical imaging techniques in drug discovery processes and preclinical research are expected to propel the growth of this market. Some prominent players in the global optical imaging market are Topcon Medical systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Carl Zeiss Meditec AG (Germany), and Bioptigen, Inc. (U.S.), Heidelberg Engineering, Inc. (U.S.), Headwall Photonics, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Optovue, Inc. (U.S.), DermaLumics (Spain), Michelson Diagnostics (U.K.), AGFA Healthcare (Belgium), and Santec Corporation (Japan). Target A

 The global artificial tendons and ligaments market is projected to reach USD 35.0 million by 2023 from USD 18.5 million in 2018, at a CAGR of 13.6%. The artificial tendons and ligaments market is emerging and fragmented in nature with various regional and international players. In 2017, the artificial tendons and ligaments market was dominated by LARS (France) and Neoligaments (UK). LARS held the leading position of the global artificial tendons and ligaments market in 2017. The company offers the Ligament Augmentation Reinforcement System (LARS) for a wide range of applications, such as soft-tissue repair and reconstruction for the treatment of knee, shoulder and arm, foot and ankle, and hip injuries. Since 1992, more than 60,000 LARS ligaments have been implanted by 400 surgeons worldwide, with more than 30,000 used for ACL alone. LARS ligaments have been successfully used for more than 25 years in a wide variety of patients ranging from the general public to elit

According to research report the  weight loss and weight management market  is expected to reach USD 245.51 billion by 2022 from USD 165.81 billion in 2016, at a CAGR of 6.9% from 2017 to 2022. Globally, the number of people suffering from obesity has increased significantly over the years. Unhealthy eating habits and sedentary lifestyles are the major factors responsible for the rising obesity rates across the globe. Governments across the globe have identified the immediate need to improve the health and well-being of the population and are taking necessary steps to increase the awareness for the same. In addition to favourable government initiatives, the awareness about health and well-being has increased among the population in several countries, and people are increasingly focusing on leading a healthy lifestyle. These factors are creating a favorable environment for the greater uptake of weight loss and weight management products and services across the globe. Maj

According to research report the coronary stent market is expected to reach USD 10.31 billion by 2021 from USD 7.16 billion in 2016, at a CAGR of 7.6% from 2016 to 2021. The market is mainly driven by factors such as technological advancements, increasing number of percutaneous coronary intervention (PCI) procedures, rising burden of CAD, increasing demand for minimally invasive procedures, and rising geriatric population. A coronary stent is a small, expandable tube-shaped device placed in the coronary arteries that supply blood to the heart. Coronary stents are used in percutaneous coronary intervention (PCI) procedures to treat patients with coronary artery disease (CAD). They are used for a wide range of indications in CAD, including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Hospitals This segment includes both government and private hospitals that provide treatment to the patients with CAD. The market

 According to research report the  Digital PCR Market  is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period. Product Launches: Key Strategy Adopted by the Major Players in this Market New product launches and approvals are the key growth strategies adopted by major players to strengthen their position in the global Digital PCR Market. Moreover, strategies such as partnerships, collaborations, and agreements; as well as mergers and acquisitions were also adopted by several market players to strengthen their market position, expand their R&D capabilities, and geographic presence in the global Digital PCR Market. The key players in the Digital PCR Market include Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc. (Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France), Fluidigm Corporatio

 The  perfusion systems market  is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021. On the basis of application, the perfusion systems market is segmented into cardiopulmonary perfusion systems, cell perfusion systems, and ex vivo organ perfusion. The cardiopulmonary perfusion systems segment accounted for the largest share of the global perfusion systems market in 2016. The large share of this segment can be attributed to the increasing prevalence of cardiovascular & respiratory diseases and the increasing number of organ transplant procedures, worldwide. Market Dynamics Drivers Increasing prevalence of cardiovascular and respiratory diseases Rising number of organ transplantations Growth in Aging Population, Increasing Incidence of Multiple Organ Failures Government and NGO Initiatives to Encourage Organ Donation Increasing Investments in Cell-Based Research Increase in Biologic Manufacturing

The coagulation analyzer market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021. Currently, point-of-care (PoC) devices are available in the market and provide rapid bedside monitoring to aid clinicians in directing appropriate targeted therapy. Majority of POC devices used today can perform multiple coagulation tests and provide high sensitivity, improved patient compliance, and decreased testing turnaround time (compared to laboratory testing coagulation analyzers) for the diagnosis and management of blood disorders. Consequently, the demand for POC testing coagulation analyzers is increasing across the globe. Due to technological advancements, dual- and four-channel systems that can be simultaneously used for testing of PT, APTT, ACT, and fibrinogen testing, have been launched in the market. Moreover, technological advancements in point-of-care procedures along with quality assurance and home testi

According to research report the  minimally invasive surgical instruments market  is projected to reach USD 21.47 Billion by 2021 from USD 13.89 Billion in 2016, at a CAGR of 9.1%. Cardiothoracic Surgery Gastrointestinal surgery Orthopedic Surgery Gynecological Surgery Vascular Surgery Cosmetic/Bariatric Surgery Urological Surgery Other applications (ENT/Respiratory Surgery, Neurological Surgery, Dental Surgery, and Pediatric Surgery) Benefits of minimally invasive surgeries over traditional open surgeries; reduction in healthcare costs and time; increasing number of surgeries among the aging population; increasing prevalence of lifestyle disorders; and technological advancements are key factors expected to drive the growth of the minimally invasive surgical instruments market. Increasing awareness of technologically advanced MIS instruments & procedures and emerging markets provide significant growth opportunities for the market. Benefits of minimally invas

The global  refurbished medical equipment market  was dominated by GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), and Siemens Healthineers (Germany) in 2015. With its broad product portfolio and strong distribution network, GE Healthcare held the leadership position in the global refurbished medical equipment market in 2015. The company offers refurbished medical devices under its brand “GoldSeal”. GE Healthcare’s product portfolio includes a wide range of refurbished medical devices, namely, GoldSeal Bone Health, GoldSeal Computed Tomography, GoldSeal Interventional X-ray, GoldSeal MRI, GoldSeal Nuclear Medicine, GoldSeal PET/CT, GoldSeal Mammography, GoldSeal RAD/R&F X-ray, and GoldSeal Ultrasound system. In the last three years, the company adopted partnerships and expansions as its key strategies to maintain its leadership position in the global refurbished medical equipment market. Philips Healthcare held the second position in the refurbished medical equipm